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Summary. Tubular cell epithelial-mesenchymal
transition (EMT) is a fundamental contributor to renal
fibrosis. The aim of this study was to investigate the
activity of different matrix metalloproteinases by
immunohistochemistry and gel-zymography in a model
of chronic canine kidney disease. Immunohistochemistry
for antibodies against MMP-9, MMP-2, MMP-13,
MMP-14 and TIMP-2 was performed on 28 renal biopsy
specimens. Selected cases were chosen for gelatin
zymography. In moderate and severe tubulo-interstitial
damage, increased expression of MMP-2 was noted. A
peculiar staining pattern for MMP-2 in variable-sized
vesicles, corresponding to the area of basement
membrane splitting, was observed. The immuno-
expression of MMP-9 and TIMP-2 was reduced in the
same cases, compared to control dogs. The splitting of
the membrane suggests an active role of this gelatinase
in the disruption of type-IV collagen, the main basement
membrane component, confirmed by MMP2
gelatinolytic activity by gel-zymography. These data
could provide the basis for clinical trials examining the
potential benefits of selective MMP-2 inhibitors in dogs
with chronic kidney disease.
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Introduction
Progressive fibrosis is a common process promoted
by epithelial remodelling (EMT), inflammation,
fibroblast activation, and reorganisation of cellular
interactions with the extracellular matrix (ECM)
(Kaissling and Le Hir, 2008; Hewitson, 2009). This
process has been suggested to be a consequence of
disequilibrium between increased ECM synthesis and
decreased matrix metalloproteinase (MMP)-mediated
degradation (Lelongt et al., 2001; Inkinen et al., 2005).
Matrix metalloproteinases (MMPs) are enzymes with
metal ion-dependent activity that degrade extracellular
matrix (ECM) glycoproteins. MMPs play a vital role in
various normal and pathological processes, including
embryogenesis, tissue remodelling, angiogenesis, wound
healing, and metastasis (Visse and Nagase, 2003; Mott
and Werb, 2004). MMPs are also important in the tissue
remodelling and repair that occurs in various renal
diseases, such as glomerulonephritis and progressive
renal fibrosis. In particular, MMP-2 and -9 have been
studied extensively in the kidneys and in renal
transplantation models of acute allograft rejection and
chronic allograft nephropathy. Notably, results from
recent clinical studies of renal allografts suggest that
MMPs and TIMPs could play a role in the development
of glomerular sclerosis and interstitial fibrosis (Johnson
et al., 2002). 
The current view of EMT postulates that it involves
a mechanism in which tubular epithelial cells become
activated by exogenous stimuli and subsequently lose
contact with neighbouring cells and the basement
membrane. After initiation of EMT, cells move through
the basement membrane into the interstitial matrix where
they become detectable as fibroblasts/myofibroblasts.
Thus, in this hypothetical model of EMT, the epithelial
phenotype is clearly associated with the TBM
microenvironment, whereas the mesenchymal phenotype
is associated with the interstitial microenvironment.
Both in vitro and in vivo studies have provided evidence
suggesting that tubular cells themselves may
transdifferentiate, acquire fibroblast-like properties, and
secrete matrix proteins, including types-I, -III, -IV and -
V collagen, into the interstitial space (El-Nahas, 2003;
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Cheng et al., 2006). We hypothesised that MMPs may
disrupt the tubular basement membrane (TBM), leading
to EMT. To test this hypothesis, we investigated the role
of MMP-2, MMP-9, MMP-13, MMP-14 and TIMP-2
during tubular interstitial damage (TID). In addition, the
activities of MMP-2 and MMP-9 were evaluated by
gelatine zymography. 
Materials and methods
Twenty-eight dogs, 17 males and 11 females, were
selected from a population of dogs presenting a positive
serology for leishmaniasis during a survey study on
Italian territory from 2004 to 2009. Portions of renal
cortex were collected immediately after euthanasia
performed when clinical conditions of the dogs were
considered irreversible. Renal tissue was formalin-fixed,
paraffin-embedded and stained for microscopic
examination. For immunohistochemical studies, we used
a commercial kit (Dako LSAB K680; Dako,
Burlingame, CA, USA) containing peroxidase-
conjugated streptavidin and a mixture of biotinylated
goat anti-rabbit and anti-mouse immunoglobulins as the
link antibody. Antibodies against MMP-2, MMP-9,
MMP-14, MMP-13 and TIMP-2 were used (Table 1).
Tissue sections cut at 3 µm were de-waxed, rehydrated
and rinsed in phosphate-buffered saline (PBS), pH 7.4.
Endogenous peroxidase activity was blocked with
hydrogen peroxide (0.3%) in absolute methanol for 30
min. The primary antibodies were applied to the
sections, which were then incubated at 4°C overnight.
The reaction was developed with 3,3’-diaminobenzidine
tetra-hydrochloride (Sigma, St Louis, MO, USA)
containing hydrogen peroxide (0.03%) and the sections
were counterstained with Periodic Acid Schiff (PAS). 
Kidney fibrosis in renal biopsies was determined on
paraffin-embedded sections (4 µ m) stained with
Masson's trichrome. The amount of fibrotic tissue was
assessed by point -counting using a 25-point grid
randomly laid on the micrographs. The tubulo-interstitial
damage grade (TID grade) was graded as follows: grade
0= no lesions or less than 5% of tubular lesions; grade
1= tubular lesions of less than 5%; fibrosis of less than
20% 5%>x<20%; grade 2= tubular lesions of less than
20%; fibrosis of less than 50% between 20%>x<50%,
and grade 3= diffuse and severe tubular atrophy and
fibrosis of greater than 50%, x> 50%. The tissue
immunoreactivity of MMP-2, MMP-9, MMP-13, MMP-
14 and TIMP-2 was assessed using a grading system
based on the percentage of tubular epithelial cells with
positive staining in the cytoplasm or cell membrane in
the cortical area. The immunohistochemical staining
results were divided into the following 4 categories
based on the total percentage of tubular epithelial cells
that stained positively; negative (-), = non-stained
epithelial tubular cells or up to <20% of epithelial
tubular epithelial cells with weak staining; weakly
positive (+), ≥20%- to <40% of epithelial tubular
epithelial cells with weak staining; moderately positive
(++), ≥40% to <60% of epithelial tubular epithelial cells
with intense staining; intensely positive (+++), greater
than ≥60% of epithelial tubular epithelial cells with
intense staining.
Immunostaining was scored by two independent
observers, and discordant scores were re-evaluated by
the investigators and the consensus score was used for
further analysis.
For gelatine zymography, samples from renal cortex
were stored at –20°C until use. MMP activity was
studied by zymography, which reveals the gelatinase
activity of latent pro-enzymes (zymogens) in addition to
that of mature MMPs. Renal tissue was subjected to
electrophoresis on 8% SDS-PAGE co-polymerised with
0.1% gelatine. Following electrophoresis, the gel was
incubated for 1 h at room temperature in a 2.5% Triton
X-100 solution, and incubated at 37°C for 16 h in
Tris–HCl buffer, pH 7.4, containing 10 mM CaCl2. The
gels were stained with 0.1% Coomassie Brilliant Blue R-
250, and then de-stained with 30% methanol and 10%
acetic acid. Gelatinolytic activities were detected as
unstained bands against the background of Coomassie
blue stained gelatine. Culture medium conditioned by
A2058 melanoma cells was co-electrophoresed as a
control to identify pro-MMP-9 gelatinolytic bands.
Digestion bands were quantified using an image analyser
system with GelDoc 2000 and Quantity One software
(BioRad, Hercules, CA, USA). The Pearson and
Spearman correlation coefficients have been used for
measuring the strength of the linear relationship between
three pair of variables (MMP-9 – Grade; TIMP-2 –
Grade and MMP-2 – Grade).
Results
Four groups of seven dogs each covering all grades
of tubulo-interstitial damage were selected for the study
(Table 2).
The expression patterns of MMP-2, MMP-9, MMP-
13, MMP-14 an(d TIMP-2 were investigated by
immunohistochemistry to determine their localisation
and staining intensity. In the normal tubular epithelial
cells, a highly granular staining pattern of MMP-9 was
detected primarily in the cytoplasm (Fig. 1a). In the
fibrotic regions and in tubules with marked thickening of
the tubular basement membrane, the diffuse loss of
immunoreactivity for MMP-9 was evident (Fig. 1b,c). In
addition, neutrophils and plasma cells exhibited positive
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Table 1. Details of antibodies.
Antigen Source Clone Dilution Manufacturer
MMP-9 Human MAB 3309 1:1000 Chemicon (Millipore) 
MMP-2 Human Ab-7 1:400 Neomarkers, Fremont, USA
TIMP-2 Human MAB 3317 1:1000 Chemicon (Millipore)
MMP-13 Human VIIIA2 1:100 Millipore Co., Billerica, USA
MMP-14 Human - 1:200 Millipore Co., Billerica, USA
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Fig. 1. Kidney sections of dogs with different TID grades. a. Control dog with strong immunopositive reaction (+++) to MMP-9. b. Immunolabelling for
MMP-9 (++) in TID grade 1. c. Immunoreactivity for MMP-9 (+) in a fibrotic area and tubules with marked thickening of the tubular basement membrane
in TID grade 2. d. Control dog with strong immunopositive reaction (+++) to TIMP-2. e. Immunolabelling for TIMP-2 (+) in TID grade 2. f. Loss of
immunoexpression of TIMP-2 in tubules in area of fibrosis in TID grade 3. Immunohistochemestry PAS- counterstained. a, x 200; b-f, x 400
immunoreactivity for MMP-9 (positive control). MMP-2
was found only in the pathological kidney (Fig. 2b). No
immunoreactivity was shown by TEC in control kidneys
and in TID grade 1 dog a minimal immunolabelling was
observed in one dog (Fig. 2a). MMP-2 was localised to
the cell surface and cytoplasm of scattered tubular
epithelial cells. Notably, we observed a peculiar staining
pattern for MMP-2 in variable-sized vesicles,
corresponding to the area of basement membrane
splitting (Fig. 2c,d). Localisation of TIMP-2 was
comparable to MMP-9 (Fig. 1b). Data for MMP-9,
MMP-2 and TIMP-2 are summarised in Table 2.
Immunoreactivity for MMP-14 was occasionally found
in a granular distribution, localised to the cytoplasm of
tubular epithelial cells, but also diffusely detected in the
cytoplasm of newly formed vascular endothelial cells
and fibroblasts. Nuclear staining was rarely identified in
310
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Fig. 2. Kidney sections of dogs with different TID grades. a. MMP-2 minimal immunolabelling (+) in TID grade 1. b. MMP-2 strong immunolabelling
(+++) in TID grade 3. c. Localization of MMP-2 in variable-sized vesicles, corresponding to the area of basement membrane splitting in TID grade 2. 
d. Vesicles of MMP-2 in the tubular basement membrane in TID grade 2. Immunohistochemestry PAS- counterstained. a-c, x 400; d, x 600
Table 2. Immunohistochemical results of MMP-9, MMP-2 and TIMP-2.
CONTROL GRADE 1 GRADE 2 GRADE 3
MMP-9 n=7 (%) n=7 (%) n=7 (%) n=7 (%)
- 0 (0) 0 (0) 2 (28.6) 6 (85.7)
+ 0 (0) 1 (24.3) 5 (71.4) 1 (24.3)
++ 0 (0) 6 (85.7) 0 (0) 0 (0)
+++ 7 (100) 0 (0) 0 (0) 0 (0)
MMP-2 n=7 (%) n=7 (%) n=7 (%) n=7 (%)
- 7 (100) 6 (85.7) 5 (71.4) 4 (57.4)
+ 0(0) 1 (24.3) 2 (28.6) 3 (42.6)
++ 0 (0) 0 (0) 0 (0) 0 (0)
+++ 0 (0) 0 (0) 0 (0) 0 (0)
TIMP-2 n=7 (%) n=7 (%) n=7 (%) n=7 (%)
- 0 (0) 0 (0) 1 (24.3) 2 (28.6)
+ 0 (0) 0 (0) 5 (71.4) 5 (71.4)
++ 0 (0) 2 (28.6) 1 (24.3) 0 (0)
+++ 7 (100) 5 (71.4) 0 (0) 0 (0)
normal epithelium. In contrast to MMP-2 and MMP-9,
MMP-13 showed no immunoreactivity in the tubular
epithelial cells in all grades of damage. Statistical results
for MMP-9-Grade are: Pearson’s r -0.946638 and
Spearman’s rho -0.943821. Since both the indices are
approximately -1, the relationship might be considered
significantly linear, i.e. immunohistochemical expression
for MMP-9 decreases compared to TID grade (Fig. 5a).
Similar results are evident for TIMP-2-Grade (Pearson's
r -0.877058 and Spearman's rho -0.879648). While
results for MMP-2-Grade do not exhibit evidence of
linear relationship (Pearson’s r 0.389249 and Spearman's
rho 0.389249) (Fig. 5b). We also plotted the differences
of immunohistochemical results for MMP-2 and TIMP-2
(Fig. 3). 
Gelatine zymography identifies and separates the
gelatinases, MMP-2 and MMP-9, in both latent and
active forms. Figure 4 shows the representative patterns
of the gelatine zymogram of various tissue samples.
Gelatinolytic activity of MMP-9 was near the detection
limit in the three control kidneys. In the five kidneys
examined with TID grade 3, we found mostly latent
MMP-9 (95 kDa) and only minor amounts of active
MMP-9 migrating at 82 kDa. MMP-2 specific activity
was increased in pathological kidneys, while totally
absent in controls. Indeed, pathological kidney extracts
contained the latent form of MMP-2 at about 72 kDa,
and considerable amounts of active MMP-2 were
detectable. 
Discussion
In the epithelial to mesenchymal transition, tubular
epithelial cell injury results in the progressive loss of
defined epithelial features, including disassembly of E-
cadherin junctional complexes and ß-catenin, and
311
Role of metalloproteinases in renal fibrosis
Fig. 4. Zymographic assay of gelatinase activity. Lanes 1 and 5: control
dogs. Lanes 2, 3, 4, 6: dogs TID grade 3.
Fig. 3. Bar diagram of the differences of immunohistochemical results
for MMP-2 and TIMP-2 according to the TID grade (immunohisto-
chemical results for MMP-2 and TIMP-2 are represented numerically).
Fig. 5. Bar diagram of the immunohistochemical results for MMP-9 and TID grade (a) and MMP-2 and TID grade (b) according to the TID grade
(immunohistochemical results for MMP-2 and TIMP-2 are represented numerically).
diminished cytokeratin expression. The loss of epithelial
features is accompanied by the acquisition of a
mesenchymal phenotype, including expression of
vimentin (Kriz et al., 1998; Hewitson, 2009; Yabuki et
al., 2009). Recent research has focused on the potential
role of MMPs as key mediators of the dissolution of the
tubular basement membrane, which in turn promotes
tubular EMT, tubular atrophy, and progressive renal
fibrosis (Zeisberg et al., 2001). Imbalances between the
synthesis and degradation of glomerular extracellular
matrix (ECM) proteins are thought to play important
roles in the progression of renal fibrosis. The MMP
family consists of about 18 members. MMP-1 and -13
are interstitial collagenases that degrade type-I and -III
collagens, whereas MMP-2 and -9 are gelatinases that
act on type-IV collagens (fibronectin and laminin are
amongst their preferred substrates). The kidney also
expresses 3 inhibitors of MMPs, TIMP-1, -2 and -3.
TIMP-2 has preferential action on MMP-2 whereas
TIMP-1 and -3 act on most MMPs. TIMP-1 and -2
directly inhibit the action of MMPs by binding to their
free catalytic sites (McCawley and Matrisan, 2001; Mott
and Werb, 2004).
We previously demonstrated that EMT in canine
renal tissue correlated with the decreased expression of
the cadherin-catenin system (Aresu et al., 2008).
However, it remains unclear whether the loss of E-
cadherin is a consequence or a cause of EMT. In
previous studies, EMT was not found to be associated
with interstitial invasion of TEC and most epithelial cells
acquired mesenchymal phenotypes and remained within
tubular structures. The aim of this work was to describe
the role of the TBM in this transition with particular
attention to localisation of MMPs. The crucial
observation seems to be the localisation of MMP-2 to
the tubular basement membrane splitting. The splitting
of the membrane suggests an active role of this
gelatinase in the disruption of type-IV collagen, the main
basement membrane component. Observations in vitro
emphasised the importance of basement membrane
organisation in the development of EMT and that it can
be induced in tubular epithelial cells after disruption of
the tubular basement membrane by MMP-2 (Zeisberg et
al., 2002; Cheng and Lovett, 2003). MMP-2
proteolytically cleaves denatured collagen (gelatine) and
has some ability to cleave native type-IV collagen, the
key structural component of the basement membrane.
Type-IV collagen is the most abundant protein in
basement membranes and acts as a scaffold to provide
structural and functional integrity. By degrading type-IV
collagen, gelatinases may also aggravate disease
progression through EMT, and migration of
phenotypically changed tubular cells through the
damaged basement membrane (Endo et al., 2006).
Enzymatic disruption of cell-cell or cell-matrix
attachments has been proposed in different studies, but
only as an alternative mechanism for induction of
epithelial-mesenchymal transformation. The TBM
provides a tightly regulated microenvironment for
normal function of tubular epithelial cells and facilitates
numerous cell-matrix interactions that are pivotal for the
maintenance of epithelial phenotypes (Visse and Nagase,
2003). MMP-2 also facilitates the production of active
TGF-1 protein, in a kind of vicious cycle that exists
within most pathways involved in progressive kidney
disease (Rao et al., 2005). 
Results from gelatine zymography demonstrate that
the active form of MMP-2 was particularly abundant in
grade 3 fibrosis. This suggests a large conversion from
latent to active form, which could be due to increased
proteolytic or oxidative activation of this MMP.
Immunohistochemical expression of MMP-9
confirms that the reduction in activity of this specific
gelatinase is associated with the progression of renal
scarring and fibrosis. Several studies have reported
predominantly intracellular MMP-9 staining in the
tubular epithelium with a similar pattern as we describe
here in dogs (Ahmed et al., 2007; Catania et al., 2007).
Obviously, MMP-9 must be synthesised within the cell
and be exported through the classical endoplasmic
reticulum, Golgi apparatus, and secretary vessel route
(Johnson et al., 2002). Unfortunately, the use of
immunohisto-chemistry rather than higher resolution
immuno-fluorescence makes it difficult to localise
MMP-9 to these structures, which would suggest
“storage before requirement” (Rao et al., 2003).
However the diffuse cytoplasmic staining and the
absence of extracellular staining raises the possibility
that MMP-9 may have an additional role in the
regulation of tubular epithelium and ECM. Nonetheless,
one cannot exclude a role in the breakdown of immature
ECM proteins before release. There are reports
suggesting that MMP-9 may act as an anti-apoptotic
factor (Lelongt et al., 2001; Laplante et al., 2003).
MMPs and TIMPs may also influence cell proliferation
and turnover. Various MMPs have been implicated in
intracellular signalling, though the precise mechanism
for these functions remains unclear. Therefore, more
detailed investigation of the functions of these molecules
in renal tubular cells is required. On the other hand,
decreased MMP-9 production or activity, correlated with
a reduction in immunohistochemical expression of
MMP-9, can lead to decreased collagen degradation with
a net accumulation of ECM proteins in the tissue. MMP-
13, together with other metalloproteases, seems to
particularly contribute to endochondral ossification, cell
enlargement during chondrocyte hypertrophy and matrix
calcification, and thus may be assumed to play a role in
skeletal development, tissue remodelling and wound
healing (Visse and Nagase, 2003). No significant data
are present on the role of MMP-13 in fibrosis. In this
study the immunostaining for MMP-13 was completely
negative, excluding a possible role of this MMP with the
other MMPs. 
In conclusion, in this work we identified the role of
TBM integrity in providing numerous cell-matrix
312
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interactions that are pivotal for the maintenance of the
epithelial phenotype. The data on MMP-2 could provide
the basis for clinical trials examining the potential
benefits of selective MMP-2 inhibitors in dogs with
chronic kidney disease.
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